Page last updated: 2024-08-21

alpha-aminopyridine and Chronic Lung Injury

alpha-aminopyridine has been researched along with Chronic Lung Injury in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bayraktutan, Z; Bilen, A; Dincer, B; Halici, Z; Keskin, H; Kose, D; Sirin, B; Toktay, E1
Eckle, T; Eltzschig, HK; Grenz, A; Laucher, S1
Cerdá-Nicolás, M; Cortijo, J; Hatzelmann, A; Iranzo, A; Mata, M; Milara, X; Morcillo, EJ; Ruiz-Saurí, A; Tenor, H1

Other Studies

3 other study(ies) available for alpha-aminopyridine and Chronic Lung Injury

ArticleYear
Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2022, Volume: 35, Issue:3

    Topics: Aminopyridines; Animals; Benzamides; Cecum; Cyclopropanes; Disease Models, Animal; Ligation; Lung; Lung Injury; NF-kappa B; Punctures; Rats; Sepsis

2022
A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.
    The Journal of clinical investigation, 2008, Volume: 118, Issue:10

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; Chimera; Extravascular Lung Water; Female; Gene Expression Regulation; Lung Injury; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pneumonia; Pulmonary Alveoli; Receptor, Adenosine A2B; Receptors, Purinergic P1; Signal Transduction; Time Factors; Ventilators, Mechanical; Xanthines

2008
Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury.
    British journal of pharmacology, 2009, Volume: 156, Issue:3

    Topics: Aminopyridines; Animals; Benzamides; Bleomycin; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Lung; Lung Injury; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Fibrosis; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction

2009